Spine device company Zavation Medical Products has appointed Lane Major as its new chief executive officer (CEO).
With more than two decades of experience in life sciences and healthcare, Major takes over the helm from the company’s founder Jeffrey Johnson, who will continue his involvement as the executive chairman of the company’s board of directors.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Johnson said: “As Zavation embarks on its next phase of growth, it is crucial that our next CEO embodies our values, shares our goals, and aligns with our long-term vision.
“Lane is an established leader in the spine industry, a great cultural fit, and deeply committed to delivering best-in-class services to our customers. I’m excited to work closely with him to build on our success and drive Zavation forward.”
Major’s extensive background includes co-founding K2M, a company known for its innovation in complex spine and minimally invasive solutions.
As COO and chief strategy officer, he was instrumental in scaling the company’s revenue to $300m.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataHis tenure at K2M was marked by achievements, including a private equity exit, an initial public offering, and the company’s eventual $1.4bn acquisition in 2018 by Stryker Corporation.
Following the acquisition, Major took on the role of vice president and general manager at Stryker, leading the spine division.
His strategic leadership was pivotal in the acquisition of Mobius Imaging and Cardan Robotics, which amounted to a $500m expansion.
Major said: “Jeffrey’s vision and unwavering commitment to delivering high-quality products and exceptional customer experiences have truly set Zavation apart.
“Together, we will continue to invest in our in-house design expertise and vertically integrated manufacturing capabilities, driving innovation to deliver cutting-edge spinal solutions for customers worldwide.”
Last year, Gemspring Capital’s portfolio company Zavation acquired CoreLink, a US-based provider of spinal implants, from the Stephens Group.
Headquartered in Flowood, Mississippi, Zavation was founded in 2012 and has since manufactured a comprehensive portfolio of spinal hardware and biologics.
